Win a New iPad! Join the Efferon LPS Photo Challenge on LinkedIn – Efferon

12 September 2025

Win a New iPad! Join the Efferon LPS Photo Challenge on LinkedIn

Efferon is launching its very first photo contest on LinkedIn! If you work with the Efferon LPS device, this is your chance to showcase your setup and creativity — and compete for a brand-new iPad.

How to Enter

Take an original photo of the Efferon LPS device integrated into circuits.
Ensure no faces are visible (silhouettes are acceptable).
Post your photo as a public post on LinkedIn.
Tag the official Efferon page and add a short caption about your setup or experience with the device.

The Prize
One winning photo will be awarded a new iPad.

Judging Criteria
Entries will be judged on creativity, photographic quality, and how well the Efferon LPS device is presented in a professional environment.

Important Notice
This contest is organized by Efferon and is not sponsored, endorsed, or administered by LinkedIn. Full contest rules, including details on data privacy and image rights, are available here.

10 December 2025

Efferon LPS® incorporated into clinical guidelines of the German Society of Nephrology for therapeutic apheresis

25 November 2025

We’ll see each other in Greece

05 November 2025

Efferon therapies are now available in Armenia!

ESICM LIVES 2025. ICMx 13 (Suppl 1), 109 (2025).

Eferon LPS NEO hemoadsorption in pediatric sepsis patients: a multicenter controlled study

Critical Care 2024, 28(Suppl 1):P220

Hemoperfusion with Efferon LPS NEO device reverts multiple organ failure, decreases IL-6 and TNF levels and systemic immune inflammation in children with sepsis

Shock. 2023 Jun 1;59(6):846-854

Hemoperfusion using the LPS-selective mesoporous polymeric adsorbent in septic shock: a multicenter randomized clinical trial

Intensive Care Medicine Experimental 2022, 10(2): 000710

Extracorporeal hemoperfusion with Efferon LPS for rapid reconstitution of vital parameters and decreasing proinflammatory biomarkers in patients with intra-abdominal sepsis

World Journal of Medical Case Reports. Vol. 2, No. 3, 2021, pp. 46-50.

Application of novel device Efferon LPS in hemoperfusion for simultaneous removal of endotoxin and cytokines in a patient with septic shock

Therapeutic archive. 2021; 93 (7): 811-817

Extracorporeal adsorption of cytokines in cytokine release syndrome in a patient with acute lymphoblastic leukemia after therapy with T cells with a chimeric antigen receptor. Clinical observation

General resuscitation. 2020; 16 (6): 31-53.

Application of adsorbent based on a hypercrosslinked styrene-divinylbenzene copolymer with an immobilized LPS-selective ligand in hemoperfusion for the treatment of patients with septic shock

General resuscitation. 2020; 16 (4): 14-20.

Hemosorption carried out by a column filled with hypercrosslinked styrene-divinibenzene copolymer with an immobilized LPS-selective ligand in a complex of intensive treatment of acute lung injury in the surgical treatment of lung cancer (clinical observation)

General resuscitation. 2018; 14 (6): 51-60.

Efficiency and safety of a new product for LPS-selective hemosorption (experimental study)

General resuscitation. 2016; 12 (6): 82-107.

Sorbents for extracorporeal removal of toxic substances and molecules with unwanted biological activity (review)